Catheter Precision, Inc. is a medical device company. It is engaged in providing new solutions to the market to improve the treatment of cardiac arrhythmias. It is focused on developing technology for electrophysiology procedures by collaborating with physicians and continuously advancing its products. It is also focused on developing and delivering electrophysiology products to provide patients, hospitals, and physicians with novel technologies and solutions to improve the lives of patients with cardiac arrhythmias. Its product is the VIVO System, which is an anacronym for View into Ventricular Onset System, which is a non-invasive imaging system that offers three-dimensional cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients. Its LockeT product is a suture retention device indicated for wound healing. Its product portfolio also includes the Amigo Remote Catheter System, a robotic arm that serves as a catheter control device.
BörsenkürzelVTAK
Name des UnternehmensCatheter Precision Inc
IPO-datumSep 27, 2018
CEOMr. David Jenkins
Anzahl der mitarbeiter22
WertpapierartOrdinary Share
GeschäftsjahresendeSep 27
Addresse1670 Highway 160 West
StadtFORT MILL
BörseNYSE American Consolidated
LandUnited States of America
Postleitzahl29708
Telefon19736912000
Websitehttps://www.ramed.com/
BörsenkürzelVTAK
IPO-datumSep 27, 2018
CEOMr. David Jenkins
In den vergangenen 5 Jahren wurden insgesamt
0.00
USD an Dividenden ausgeschüttet.

Keine Daten